GSK3α enzyme identified as a checkpoint in stem cell fate – when inhibited, self-renewal capacity is maintained
The defining features of stem cells is their potential to develop into multiple cell types and their ability to self-renew. This self-renewal capacity ensures the maintenance of stem cell reservoirs in the body and, if scientists can harness it effectively, in the laboratory too. When maintaining stem cell cultures in the lab, scientists typically use different concoctions of factors specific to the different types of stem cells. But recent research has identified a common checkpoint protein – the regulatory kinase GSK3 – that, when inhibited, maintains self-renewal capacity in multiple stem cell types across multiple species. Indeed, GSK3 inhibition allowed the mouse epiblasts and embryonic stem cells, pictured (green and red), to be cultured together and yet maintain their individual identities – hitherto impossible. In addition to improving stem cell culture techniques, the discovery of the common GSK3 checkpoint could possibly be leveraged clinically to improve the health and healing of ageing tissues.
Written by
BPoD stands for Biomedical Picture of the Day. Managed by the MRC Laboratory of Medical Sciences until Jul 2023, it is now run independently by a dedicated team of scientists and writers. The website aims to engage everyone, young and old, in the wonders of biology, and its influence on medicine. The ever-growing archive of more than 4000 research images documents over a decade of progress. Explore the collection and see what you discover. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.